# A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer

> **NCT07699328** · PHASE1,PHASE2 · RECRUITING · sponsor: **Voronoi, Inc** · enrollment: 315 (estimated)

## Conditions studied

- EGFR-Mutant Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** VRN110755

## Key facts

- **NCT ID:** NCT07699328
- **Lead sponsor:** Voronoi, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-26
- **Primary completion:** 2029-01-01
- **Final completion:** 2029-01-01
- **Target enrollment:** 315 (ESTIMATED)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07699328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07699328, "A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07699328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*